The list of publications below are those dealing with lymphatic filariasis. This will be updated regularly.

This is a bibliographic list only. No downloads are possible. Search for abstracts in PubMed.

1. Addiss DG, Dreyer G. Treatment of Lymphatic Filariasis. In. Geneva: WHO. p. 151-199.
2. Addiss DG, Eberhard ML, Lammie PJ. "Filarial" adenolymphangitis without filarial infection. The Lancet 1994;343:597.
3. Akogun OB, Audu Z, Weiss MG, Adelakun AO, Akoh JI, Akogun MK, et al. Community-directed treatment of onchocerciasis with ivermectin in Takum, Nigeria. Tropical Medicine & International Health 2001;6(3):232-243.
4. Albonico M, Ramsan M, Wright V, Jape K, Haji HJ, Taylor M, Savioli L, Bickle. Soil-transmitted nematode infections and mebendazole treatment in Mafia Island schoolchildren. Annals of Tropical Medicine & Parasitology 2002;96(7):717-726.
5. Alexander NDE, Grenfell BT. The effect of pregnancy on Wuchereria bancrofti microfilarial load in humans. Parasitology 1999;119:151-156.
6. Allen JE, Loke PN. Divergent roles for macrophages in lymphatic filariasis. Parasite Immunology 2001;23:345-352.
7. Andeasen SO, Thomsen AR, Koteliansky VE, et al. Expression and functional importance of collagen-binding integrins, ab and ab, on virus-activated T cells. The Journal of Immunology 2003;171:2804-2811.
8. Andrus JK, de Quadros CA, Olive J-M. The surveillance challenge: final stages of eradication of poliomyelitis in the Americas. Morbidity and Mortality Weekly Report 1992;41(NSS-1):21 (6).
9. Andrus JK, Strebel PM, de Quadros CA, Olive J-M. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91. Bulletin of the World Health Organization 1995;73(1):33-38.
10. Appawu MA, Dadzie SK, Baffoe-Wilmot A, Wilson MD. Lymphatic filariasis in Ghana: entomological investigation of transmission dynamics and intensity in communities served by irrigation systems in the Upper East Region of Ghana. Tropical Medicine & International Health 2001;6(7):511-516.
11. Babu S, Porte P, Kleri TR, Shultz LD, Rajan TV. Host NK cells are required for the growth of the human filarial parasite Brugia malayi in mice. The Journal of Immunology 1998;161:1428-1432.
12. Bal MS, Beuria MK, Mandal NN, Das MK. Antigenemia is associated with low antibody response to carbohydrate determinants of a filarial surface antigen. Parasite Immunology 2003;25:107-111.
13. Bancroft AJ, Grencis RK, Else KJ, Devaney E. Cytokine production in BALB/c mice immunized with radiation attenuated third stage larvae of the filarial nematode, Brugia pahangi. The Journal of Immunology 1993;150(4):1395-1402.
14. Bartoloni A, Cancrini G, Bartalesi F, Roselli M, Barahona HG. Letters to the Editor. Tropical Medicine & International Health 2000;5(11):833.
15. Beebe NW, Bockarie B, Ellis JT, Cooper RD. Differential ecology of Anopheles punctulatus and three members of the Anopheles farauti complex of mosquitoes on Guadalcanal, Solomon Islands, identified by PCR-RFLP analysis. Medical & Veterinary Entomology 2000;14(3):308.
16. Beebe NW, Maung J, Hurk AFvd, Ellis JT, Cooper RD. Ribosomal DNA spacer genotypes of the Anopheles bancroftii group (Diptera: Culicidae) from Australia and Papua New Guinea. Insect Molecular Biology 2001;10(5):407-413.
17. Belizario VY, Amarillo ME, Leon WUd, Reyes AEdl, Bugayong MG, Macatangay BJC. A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichurisspp. Bulletin of the World Health Organization 2003;81(1):35-42.
18. Beuria MK, Bal MS, Mandal NN, Das MK. Antigenemia at 10 years after diethylcarbamazine treatment of asymptomatic microfilaraemic individuals: marginal conversion to infection-free state. Parasite Immunology 2002;24(2):109-111.
19. Bockarie MJ, Fischer P, Williams SA, Zimmerman PA, Griffin L, Alpers MP, Kazura JW. Application of a polymerase chain reaction-elisa to detect Wuchereria bancrofti in pools of wild-caught Anopheles punctulatus in a filariasis control area in Papua New Guinea. American Journal of Tropical Medicine & Hygiene 2000;62(3):363-367.
20. Bockarie MJ, Hii JLK, Alexander NDE, Bockarie F, Dagoro H, Kazura JW, et al. Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival. Medical and Veterinary Entomology 1999;13:120-123.
21. Bockarie MJ, Tavul L, Kastens W, Michael E, Kazura JW. Impact of untreated bednets on prevalence of Wuchereria bancrofti transmitted by Anopheles farauti in Papua New Guinea. Medical and Veterinary Entomology 2002;16(1):116.
22. Böhm M, Riemann B, Luger TA, Bonsmann G. Bilateral upper limb lymphoedema associated with psoriatic arthritis: a case report and review of the literature. British Journal of Dermatology 2000;143(6):1297-1301.
23. Brown KR, Ricci FM, Ottesen EA. Ivermectin: effectiveness in lymphatic filariasis. Parasitology 2000;121:S133-S146.
24. Burkott TR, Ichimori K. The PacELF prgramme: will mass drug administration be enough? Trends in Parasitology 2002;18:3:109-115.
25. Burkott TR, Taleo G, Toeaso V, Ichimori K. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S61-S69.
26. Cataisson C, Joseloff E, Murillas R, et al. Activation of cutaneous protein kinase ca induces keratinocyte apoptosis and intraepirdermal inflammation by independent signaling pathways. The Journal of Immunology 2003;171:2703-2713.
27. Chadee DD, Rawlins SC, Tiwari TSB. Short communication: Concomitant malaria and filariasis infections in Georgetown, Guyana. Tropical Medicine & International Health 2003;8(2):140.
28. Chadee DD, Williams SA, Ottesen EA. Xenomonitoring of Culex quinquefasciatus mosquitoes as a guide for detecting the presence or absence of lymphatic filariasis: a preliminary protocol for mosquito sampling. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S47-S53.
29. Chang MS. Operational issues in the control of the vectors of Brugia. Annals of Tropical Medicine & Parasitology 2002:96(Supplement 2):S71-S76.
30. Chen B, Harbach RE, Butlin RK. Molecular and morphological studies on the Anopheles minimus group of mosquitoes in southern China: taxonomic review, distribution and malaria vector status. Medical and Veterinary Entomology 2002;16(3):253-265.
31. Clasen TF. Editorial: The public-private partnership for the Central American handwashing initiative: reflections from a private sector perspective. Tropical Medicine & International Health 2002;7(3):197-200.
32. Cline BL, Savioli L, Neira M. Introduction: Opportunities to work together: intestinal helminth control and programmes to eliminate lymphatic filariasis. Parasitology 2000;121:S3-S4.
33. Cookson, W. Genetics and genomics of asthma and allergic diseases. Immunological Reviews 2002;190:195-206.
34. Curtis CF, Davies CR. Present use of pesticides for vector and allergen control and future requirements. Medical & Veterinary Entomology 2001;15(3):231-235.
35. Curtis CF, Malecela-Lazaro M, Reuben R, Maxwell CA. Use of floating layers of polystrene beads to control populations of the filaria vector Culex quinquefasciatus. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S97-S104.
36. Das PK, Ramaiah KD. Entomological monitoring of annual mass drug administrations for the control or elimination of lymphatic filaraisis. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S139-S142.
37. de Almeida AB, Freedman DO. Epidemiology and immunopathology of bancroftian filariasis. Microbes and Infection 1999;1:1015-1022.
38. Dean M. Towards the elimination of lymphatic filariasis. The Lancet 2002;359:1677.
39. Deehan MR, Frame MJ, Parkhouse RME, et al. A phosphorylcholine-containing filarial nematode-secreted product disrupts B Lymphocyte activation by targeting key proliferative signaling pathways. The Journal of Immunology 1998;160:2692-2699.
40. Devaney E, Yazdanbakhsh M. Editorial: Prospects and challenges in lymphatic filariasis. Parasite Immunology 2001;23:323-325.
41. Devaney E, Gillan V, Wheatley I, Jenson J, O'Connor R, Balmer P. Interleukin-4 influences the production of microfilariae in a mouse model of Brugia infection. Parasite Immunology 2002;24(1):29-37.
42. DeVries CR. The role of the urologist in the treatment and elimination of lymphatic filariasis worldwide. BJU International 2002;89(1):37.
43. Dissanayake S. In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease. International Journal of Epidemiology 2001;30:394-399.
44. Dissanayake S, Khan N, Shahin A, Wijesinghe S, Lukic M. Induction of immunoglobulin G1, interleukin-6 and interleukin-10 by Taenia crassiceps metacestode carbohydrates. Immunology 2002;107:411-419.
45. Dreyer G, Ottesen EA, Galdina E, Andrade L, Rocha A, Medeiros Z, et al. Renal abnormalities in microfilaremic patients with bancroftian filariasis. American J Tropical Medicine & Hygiene 1992;46(6):745-751.
46. Dreyer G, Brand AC, Amaral F, Medeiros Z, Addiss D. Detection by Ultrasound of Living Adult Wuchereria bancrofti in the Female Breast. Mem Inst Oswaldo Cruz, Rio de Janeiro 1996;91(1):95-96.
47. Dreyer G, Medeiros Z, Netto MJ, Leal NC, Castro LGd, Piessens WF. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Transactions of the Royal Society of Tropical Medicine and Hygiene 1999;93:413-417.
48. Dreyer G, Dreyer P, Piessens WF. Extralymphatic disease due to bancroftian filariasis. Brazilian J Medical & Biological Research 1999;32(12):1467-1472.
49. Dreyer G, Santos A, Noroes J, Addiss D. Proposed panel of diagnostic criteria, including the use of ultrasound, to refine the concept of ‘endemic normals’ in lymphatic filariasis. Tropical Medicine and International Health 1999;4(8):575-579.
50. Dzodzomenyo M, Simonsen PE. Bancroftian filariasis in an irrigation project community in southern Ghana. Tropical Medicine & International Health 1999;4(1):13-18.
51. Eisenbeiss WF, Apfel H, Meyer TF. Protective immunity linked with a distinct developmental stage of a filarial parasite. Journal of Immunology 1994;152:735-742.
52. Elson LH, Nutman TB, Metcalfe DD, Prussin C. Flow cytometric analysis for cytokine production indentifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+ CD27- lymphocyte subpopulation. The Journal of Immunology 1995;154:4294-4301.
53. Esashi Em Sekiguchi T, Ito H, et al. Cutting edge: a possible role for CD4⁺ thymic macrophages as professional scavengers of apoptotic thymocytes. The Journal of Immunology 2003;171:2773-2777.
54. Esterre P, Plichart C, Sechan Y, Nguyen NL. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Tropical Medicine and International Health 2001;6(3):190-195.
55. Eubank Td, Galloway M, Montague CM, et al. M-CSF induces vascular endothelial growth factor productiona dn angiogenic activity from human monocytes. The Journal of Immunology 2003;171:2637-2643.
56. Falcone FH, Loke P, Zang X, et al. A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection. The Journal of Immunology 2001;167:5348-5354.
57. Faulkner H, Gardon J, Kamgno J, Enyong P, Boussinesq M, Bradley JE. Antibody responses in onchocerciasis as a function of age and infection intensity. Parasite Immunology 2001;23(9):509-516.
58. Fontes G, Rocha EM, Brito AC, Antunes CMF. Lymphatic Filariasis in Brazilian Urban Area (MaceiÛ, Alagoas). Mem Inst Oswaldo Cruz, Rio de Janeiro 1998;93(6):705-710.
59. Forestal CA, Benach JL, Carbonara C, et al. Francisella tularensis selectively induces proinflammatory changes in endothelial cells. The Journal of Immunology 2003;171:2563-2570.
60. Freedman DO, Plier DA, de Almeida AB, et al. Biased TCR repertoire in infiltrating lesional T cells in human Bancroftian filariasis. The Journal of Immunology 199;162:1756-1764.
61. Freedman DO, Plier DA, Almeida ABd, Oliveira ALd, Miranda J, Braga C. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis. Tropical Medicine and International Health 2001;6(1):37-41.
62. Gasarasi DB, Premji ZG, Mujinja PGM, Mpembeni R. Acute adenolymphangitis due to bancroftian filariasis in Rufiji district, south east Tanzania. ACTA Tropica 2000;75(1):19-28.
63. Gbakima AA, Bockarie MJ, Sahr F, et al. Rapid assessment of the prevalence and distribution of lymphatic filariasis in Sierra Leone. Annals of Tropical Medicine & Parasitology 2000;94(3):299-301.
64. Godal T. Immunization against poverty. Tropical Medicine & International Health 2000;5(3):160-166.
65. Gomella LG, Shenot P, Abdel-Meguid TA. Extraperitoneal laparoscopic nephrolysis for the treatment of chyluria. British Journal of Urology 1998;81(2):320-321.
66. Goodridge HS, Wilson EH, Harnett W, et al. Modulation of macrophage cytokine production by ES-62, a secreted product of the filarials nematode Acanthocheilonema viteae. The Journal of Immunology 2001;167:940-945.
67. Gray CA, Lawrence RA. Interferon- ¡ and nitric oxide production are not required for the immune-mediated clearance of Brugia malayi microfilariae in mice. Parasite Immunology 2002;24(6):329-336.
68. Grieve RB, Frank GR, Mika-Grieve M, et al. Identification of Dirofilaria immitis larval antigens with immunoprophylactic potential using sera from immune dogs. The Journal of Immunology 1992;148(8):2511-2515.
69. Grohmann U, Bianchi R, Orabona C, et al. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. The Journal of Immunology 2003;171:2581-2587.
70. Gupta S, Sodhani P, Jain S, Kumar N. Microfilariae in association with neoplastic lesions: report of five cases. Cytopathology 2001;12(2):120-126.
71. Gyapong J, Gyapong M, Owusu-Banahene G, Wamae N, Njenga SM, Mukoko DN. Community-Directed Treatment of Lymphatic Filariasis in Africa. Report of a multi-centre study in Ghana and Kenya. Geneva: WHO; 2000. Report No.: TDR/IDE/RP/CDTI/00.2.
72. Gyapong M. Socio-Cultural Aspects of Lymphatic Filariasis and The Role of Communities in its Control in Ghana.; 2000.
73. Haarbrink M, Terhell AJ, Abadi K, Asri M, Medeiros Fd, Yazdanbakhsh M. Anti-filarial IgG4 in men and women living in Brugia malayi-endemic areas. Tropical Medicine & International Health 1999;4(2):93-97.
74. Hancock WW, Tsai T-L, Madaio MP, Gasser DL. Multiple autoimmune pathways in kd/kdmice. The Journal of Immunology 2003;171:2778-2781.
75. Harms G, Feldmeier H. Review: HIV infection and tropical parasitic diseases -deleterious interactions in both directions? Tropical Medicine & International Health 2002;7(6):479-488.
76. Hartmann S, Schönemeyer A, Sonnenburg B, Vray B, Lucius R. Cystatins of filarial nematodes up-regulate the nitric oxide production of interferon--activated murine macrophages. Parasite Immunology 2002;24(5):253-262.
77. Hartmann S, Sollwedel A, Hoffmann A, et al. Characterization of IgE responses in a rodent model of filariasis and the allergenic potential of filarial antigens using an in vitro assay Parasite Immunology 2003;25:9-16.
78. Hashimoto H, Kapiga SH, Murata Y. Mass treatment with nevirapine to prevent mother-to-child transmission of HIV/AIDS in sub-Saharan African countries. The Journal of Obstetrics and Gynaecology Research 2002;28(6):313-320.
79. Helmy H, Weil GJ, Faris R, Gad AM, Chandrashekar R, Ashour A, et al. Human antibody responses to Wuchereria bancrofti infective larvae. Parasite Immunology 2000;22(2):89-96.
80. Hettiaratchi UPK, Munasingha DHN, Chandrasekharan NV, et al. A polymerase chain reaction based method for the detection of Culex quinquefasciatus (Diptera: Culicidae). Bulletin of Entomological Research 2000;90:63-68.
81. Heukelbach J, Mencke N, Feldmeier H. Editorial: Cutaneous larva migrans and tungiasis: the challenge to control zoonotic ectoparasitoses associated with poverty. Tropical Medicine & International Health 2002;7(11):907-910.
82. Heukelbach J, van Haef E, Rump B, et al. Parasitic skin diseases: health care-seeking in a slum in north-east Brazil. Tropical Medicine and International Health 2003;8(4):368-373.
83. Hladik F, Desbien A, Lang J, et al. Most highly exposed seronegative men lack HIV-1-specific, IFN-¡-secreting T cells. The Journal of Immunology 2003;171:2671-2683.
84. Hoffmann KF, James SL, Cheever AW, et al. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2- type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. The Journal of Immunology 1999;163:927-938.
85. Hogan MB, Weissman DN, Hubbs AF, et al. Regulation of eosinophilopoiesis in a murine model of asthma. The Journal of Immunology 2003;171:2644-2651.
86. Hogarth PJ, Bianco AE. IL-5 dominates cytokine responses during expression of protective immunity to Onchocerca lienalis microfilariae in mice. Parasite Immunology 1999;21(2):81-88.
87. Hogarth PJ, Bianco AE. Interleukin 12 modulates Tcell responses to microfilariae but fails to abrogate interleukin5dependent immunity in a mouse model of onchocerciasis. Immunology 1999;98(3):406-412.
88. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology 2000;121:S113-S132.
89. Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario et al. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 2000;121:S147-S160.
90. Hotez PJ, Zheng F, Long-qi X, Ming-gang C, et al. Emerging and reemerging helminthiases and the public health of China. Emerging Infectious Diseases 1997;3(3):303-310.
91. Hoti SL, Vasuki V, Lizotte MW, et al. Detection of Brugia malayi in laboratoryand wild-caught Mansonioides mosquitoes (Diptera: Culicidae) using Hha I PCR assay. Bulletin of Entomological Research 2001;91:87-92.
92. Hoti SL, Patra KP, 1 VV, Lizotte MW, Hariths VR, Sushma N, et al. Evaluation of Ssp I polymerase chain reaction assay in the detection of Wuchereria bancrofti infection in field-collected Culex quinquefasciatus and its application in the transmission studies of lymphatic filariasis. Journal of Applied Entomology 2002;126(7-8):417-421.
93. Houston R. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes. Parasitology 2000;121:S161-173.
94. Hussain R, Poindexter RW, Ottesen EA. Predominant localization of blocking antibody to the IgG4 subclass. The Journal of Immunology 1992; 148(9):2731-2737.
95. Kabir KE, Khan AR, Mosaddik MA. Goniothalamin – a potent mosquito larvicide from Bryonopsis laciniosa L. J. Appl. Ent. 2003;127:112-115.
96. Katabarwa MN, Habomugisha P, Agunyo S. Involvement and performance of women in community-directed treatment withivermectin for onchocerciasis control in Rukungiri District, Uganda. Health & Social Care in the Community 2002;10(5):382-393.
97. Katabarwa NM, Richards FO, Ndyomugyenyi R. In rural Ugandan communities the traditional kinship/clan system is vital to the success and sustainment of the African Programme for Onchocerciasis Control. Annals of Tropical Medicine & Parasitology 2000;94(5):485-495.
98. Kekre NS, Arun N, Date A. Retroperitoneal cystic lymphangioma causing. British Journal of Urology 1998;81(2):327-328.
99. Kibbelaar RE, Hol C, Polderman AM, Graaf Hd, Klinkert P. Filaria in an axillary lymph node dissection specimen. Histopathology 2000;37(1):85-86.
100. King CL, Hakimi J, Shata MT, Medhat A. IL-12 regulation of parasite antigen-driven IgE productin in human helminth infections. The Journal of Immunology 1995;155:454-461.
101. King CL, Malhotra I, Mungai P, et al. B cell sensitization to helmnithic infection develops in utero in humans. The Journal of Immunology 1998; 160:3578-3584.
102. King CL. Transmission intensity and human immune responses to lymphatic filariasis. Parasite Immunology 2001;23:363-371.
103. King CL, Connelly M, Alpers MP, et al. Transmission intensity determines lymphocyte responsiveness and cytokine bias in human lymphatic filariasis. The Journal of Immunology 2001;166:7427-7436.
104. King CL, Malhotra I, Wamachi A, et al. Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. The Journal of Immunology 2002;168:356-364.
105. Kinnamon KE, Engle RR, Poon BT, et al. Polyamines: agents with macrofilaricidal activity. Annals of Tropical Medicine & Parasitology 1999;93(8):851-858.
106. Koga S, Nagata Y, Arakaki Y, Matsuoka M, Ohyama C. Unilateral pedal lymphography in patients with filarial chyluria. BJU International 2000;85(3):222-223.
107. Krishnamoorthy K, Ramu K, Srividya A, Appavoo N, Saxena N, Lal S, et al. Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis. Indian J Med Res 2000;111:81-89.
108. Krishnamoorthy K, Rajendran R, Sunish IP, Reuben R. Cost-effectiveness of the use of vector control and mass drug administration, separately on in combination, against lymphatic filaraisis. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S77-S90.
109. Kurniawan A, Yazdanbakhsh M, van Ree R, et al. Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. The Journal of Immunology. 1993;150(9):3941-3950.
110. Lardeux F, Cheffort J. Ambient temperature effects on the extrinsic incubation period of Wuchereria bancrofti in Aedes polynesiensis: implications for filariasis transmission dynamics and distribution in French Polynesia. Medical and Veterinary Entomology 2001;15:167-176.
111. Lardeux F, Riviere F, Sechan Y, Loncke S. Control of the Aedes vectors of the dengue viruses and Wuchereria bancrofti: the French Polynesian experience. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S105-S116.
112. Lawrence RA, Allen JE, Osborne J, Maizels RM. Adult and microfilarial stages of the filarial parasite Brugia malayi stimulate contrasting cytokine and Ig isotype responses in BALB/c mice. The Journal of Immunology 1994; 153:1216-1224.
113. Lawrence RA, Devaney E. Lymphatic filariasis: parallels between the immunology of infection in humans and mice. Parasite Immunology 2001;23(7):353 - 361.
114. Lindsay SW, Jawara M, Paine K, Pinder M, Walraven GEL, Emerson PM. Changes in house design reduce exposure to malaria mosquitoes. Tropical Medicine and International Health 2003;8(6):512-517.
115. Liwski RS, Lee TDG. Nematode infection enhances survival of activated T cells by modulating accessory cell function. The Journal of Immunology 1999;163:5005-5012.
116. Lorenzo S, Iglesias R, Audícana MT, García-Villaescusa R, Pardo F, Sanmartín ML, et al. Human immunoglobulin isotype profiles produced in response to antigens recognized by monoclonal antibodies specific to Anisakis simplex. Clinical & Experimental Allergy 1999;29(8):1095-1101.
117. MacDonald AS, Maizels RM, Lawrence RA, et al. Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites. The Journal of Immunology 1998;160:4124-4132.
118. Magnaval J-F, Berry A, Fabre R, Morassin B. Eosinophil cationic protein as a possible marker of active human Toxocara infection. Allergy 2001;56:1096-1099.
119. Mahanty S, King CL, Kumaraswami V, et al. IL-4- and IL-5- secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. The Journal of Immunology 1993;151(7): 3704-3711.
120. Maizels RM, Blaxter ML, Scott AL. Immunological genomics of Brugia malayi: filarial genes implicated in immune evasion and protective immunity. Parasite Immunology 2001;23(7):327-344.
121. Malhotra I, Mungai P, Wamachi A, et al. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. The Journal of Immunology 1999;162:6843-6848.
122. Manga L. Vector-control synergies, between 'Roll Back Malaria' and the Global Programme to Eliminate Lymphatic Filariasis, in the African Region. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S129-S132.
123. Mani TR, Rajendran R, Munirathinam A, Sunish P, Abdullah SM, Augustin DJ, et al. Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India. Tropical Medicine & International Health 2002;7(6):541-548.
124. Mayor M, Burón I, Mora JCd, Lázaro TE, Hernández-Cano N, Rubio FA, et al. Mondor's disease. International Journal of Dermatology 2000;39(12):922-925.
125. McInnes IB, Leung BP, Harnett M, et al. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. The Journal of Immunology 2003; 171:2127-2133.
126. Medeiros Z, Gomes J, Béliz F, Coutinho A, Dreyer P, Dreyer G. Screening of army soldiers for Wuchereria bancrofti infection in the metropolitan Recife region, Brazil: implications for epidemiological surveillance. Tropical Medicine & International Health 1999;4(7):499-505.
127. Melrose WD. Lymphatic filariasis: new insights into an old disease. International Journal for Parasitology 2002;32:947-960.
128. Meyrowitsch DW, Simonsen PE. Short communication: Efficacy of DEC against Ascaris and hookworm infections in school children. Tropical Medicine & International Health 2001;6(9):739-742.
129. Michael E, Grenfell BT, Isham VS, et al. Modelling variability in lymphatic filariasis: macrofilarial dynamics in the Brugia pahangi-cat model. Proceedings of the Royal Society of London 1998;265:155-165.
130. Michael E. The control of human filariases. Current Opinion in Infectious Diseases 1999;12:565-578.
131. Michael E, P.E.Simonsen, Malecela M, Jaoko WG, Pedersen EM, Mukoko D, et al. Transmission intensity and the immunoepidemiology of bancroftian filariasis in East Africa. Parasite Immunology 2001;23:373-388.
132. Mohanty MC, Satapathy AK, Sahoo PK, Ravindran B. Human bancroftian filariasis - a role for antibodies to parasite carbohydrates. Clinical & Experimental Immunology 2001;124(1):54-61.
133. Molyneux DH. Patterns of change in vector-borne diseases. Annals of Tropical Medicine & Parasitology 1997;91(7):827-839.
134. Molyneux DH, Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S15-S40.
135. Moody AH, Chiodini PL. Methods for the detection of blood parasites. Clinical & Laboratory Haematology 2000;22(4):189-202.
136. Morrone A, Franco G, Toma L, Tchangmena O, Marangi M. A case of loiasis in Rome. Journal of the European Academy of Dermatology & Venereology 2002;16(3):280-283.
137. Mountford AP, Pearlman E. Interleukin-12 and the host response to parasitic helminths; the paradoxical effect on protective immunity and immunopathology. Parasite Immunology 1998;20(11):509-517.
138. Mpagi JL, Büttner DW, Tischendorf FW, Erttmann KD, Brattig NW. Humoral responses to a secretory Onchocerca volvulus protein: differences in the pattern of antibody isotypes to recombinant Ov20/OvS1 in generalized and hyperreactive onchocerciasis. Parasite Immunology 2000;22(9):455-460.
139. Mukhopadhyay S, Sahoo PK, George A, et al. Delayed clearance of filarial infection and enhanced Th1 immunity due to modualtion of macrophage APC functions in xid mice. The Journal of Immunology 1999;163:875-883.
140. Mukhopadhyay S, Mohanty M, Mangla A, et al. Macrophage effector functions controlled by Bruton Tyrosine Kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance. The Journal of Immunology 2002;168:2914-2921.
141. Mwobobia IK, Muniu EM, Kombi Y, et al. Hydrocelectomy: a proxy for hydrocele prevalence in coastal Kenya. Annals of Tropical Medicine & Parasitology 2000;94(5):479-484.
142. Murphy MJ, Kogan B, Carlson JA. Granulomatous lymphangitis of the scrotum and penis. Report of a case and review of the literature of genital swelling with sarcoidal granulomatous inflammation. Journal of Cutaneous Pathology 2001;28(8):419-424.
143. Nanda B, Krishnamoorthy K. Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India. Tropical Medicine and International Health 2003;8(1):56-59.
144. Nanda B, Ramaiah KD. Lymphoedema-management measures practised by cases of chronic lymphatic filariasis. Annals of Tropical Medicine & Parasitology 2003;97(4):427-431.
145. Nicolas L, Plichart C, Nguyen L, Moulia-Pelat J. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. Journal of Infectious Diseases 1997;175:489-492.
146. Nossal GJ. Gates, GAVI, the glorious global funds and more: All you ever wanted to know. Immunology and Cell Biology 2003;81(1):20-22.
147. Nutman TB. Lymphatic filariasis: new insights and prospects for control. Current Opinion in Infectious Diseases 2001;14:539-546.
148. Nutman TB, Kumaraswami V. Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India. Parasite Immunology 2001;23:389-399.
149. Okada S, Li Q, Whitin JC, et al. Intracellular mediators of granulysin-induced cell death. The Journal of Immunology 2003;171:2556-2562.
150. Okazaki T, Pendleton, CD, Lemonnier F, Berzofsky JA. Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen. The Journal of Immunology 2003;171:2548-2555.
151. O'Lorcain P, Holland, CV. The public health importance of Ascaris lumbricoides. Parasitology 2000;121:S51-S71.
152. Ottesen EA. Towards Eliminating Lymphatic Filariasis. In: Communicable Disease Eradication and Elimination. Geneva: World Health Organisation. p. 201-215.
153. Ottesen EA. The human filariases: new understandings, new therapeutic strategies. Current Opinion in Infectious Diseases 1994;7:550-558.
154. Ottesen EA, Duke BOL, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of the World Health Organization 1997;75(6):491-503.
155. Ottesen EA, lsmail MM, Horton J. The Role of Albendazole in Programmes to Eliminate Lymphatic Filariasis. Parasitology Today 1999;15(9):382-386.
156. Ottesen EA. Editorial: The Global Programme to Eliminate Lymphatic Filariasis. Tropical Medicine & International Health 2000;5(9):591-594.
157. Pani SP, Hoti SL, Elango A, Yuvaraj J, Lall R, Ramaiah KD. Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India. Tropical Medicine & International Health 2000;5(5):359-363.
158. Pani S, Reddy GS, Das L, Vanamail P, Hoti S, Ramesh J, et al. Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study. Filaria Journal 2002;1(1).
159. Park H-S, Francis KP, Yu J, Cleary PP. Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen Group A Streptococcus. The Journal of Immunology 2003;171:2532-2537.
160. Patel A, Hogan P, Walder B. Crusted scabies in two immunocompromised children: Successful treatment with oral ivermectin. Australasian Journal of Dermatology 1999;40(1):37-40.
161. Pearlman E, Heinzel FP, Hazlett FE, Kazura JW. IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi. The Journal of Immunology 1995;154:4658-4664.
162. Pedersen EM, Kilama WL, Swai ABM, Kihamia CM, Rwiza H, Kisumku UM. Bancroftian filariasis on Pemba Island, Zanzibar, Tanzania: An update on the status in urban and semi-urban communities. Tropical Medicine & International Health 1999;4(4):295 - 301.
163. Pedersen EM, Mukoko DA. Impact of insecticide-treated materials on filaria transmission by the various species of vector mosquito in Africa. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S91-S95.
164. Pichon G. Limitations and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S143-S152.
165. Plaisier AP, Cao WC, Van Oortmarssen GJ, Habbema JDF. Efficacy of ivermectin in the treatment of Wuchereria bancrofti infection: a model-based analysis of trial results. Parasitology 1999;119:385-394.
166. Prasittisuk C. Vector-control synergies, between 'Roll Back Malaria' and the Global Programme to Eliminate Lymphatic Filariasis, in South-east Asia. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S133-S137.
167. Proceedings and transactions of the VIIIth International Congress of Dermatology. International Journal of Dermatology 1999;38(12):939.
168. Rahmah N, Lim BH, Azian H, Ramelah TST, Rohana AR. Short communication: Use of a recombinant antigen-based ELISA to determine prevalence of brugian filariasis among Malaysian schoolchildren near Pasir Mas, Kelantan - Thailand border. Tropical Medicine & International Health 2003;8(2):158 - 163.
169. Ramaiah KD, Guyatt H, Ramu K, Vanamail P, Pani SP, Das PK. Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India. Tropical Medicine & International Health 1999;4(1):19-25.
170. Ramaiah KD, Vijay Kumar K. Effect of lymphatic filariasis on school children. ACTA Tropica 2000;76:197-199.
171. Ramaiah KD, Radhamani MP, Johns KR, et al. The impact of lymphatic filariasis on labour inputs in southern India: results of a multi-site study. Annals of Tropical Medicine & Parasitology 2000;94(4):353-364.
172. Ramaiah KD, Das PK, N.C.Appavoo, K.Ramu, J.Augustin D, Kumar KNV, et al. A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Tropical Medicine and International Health 2000;5(12):842-847.
173. Ramaiah KD, Kumar KNV, Chandrakala AV, Augustin DJ, Appavoo NC, Das PK. Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Tropical Medicine and International Health 2001;6(12):1062-1069.
174. Ramaiah KD, Vanamail P, Pani SP, Yuvaraj J, Das PK. The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination. Tropical Medicine & International Health 2002;7(9):767.
175. Ramzy RMR. Field application of PCR-based assays for monitoring Wuchereria bancrofti infection in Africa. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S55-S59.
176. Ramzy RMR, El Setouhy M, Helmy H, Kandil AM, Ahmed ES, Farid HA, Faris R, Weil GJ. The impact of single-dose diethylcarbamazine treatment of bancroftian filariasis in a low-endemicity setting in Egypt. American Journal of Tropical Medicine and Hygiene 2002;67(2):196-200.
177. Ravindran B, Satapathy AK, Sahoo PK, Geddam JJB. Protective immunity in human Bancroftian filariasis: inverse relationship between antibodies to microÆlarial sheath and circulating fiarial antigens. Parasite Immunology 2000;22:633-637.
178. Reddy GS, Vengatesvarlou N, P. K. Das 2 PV, Vijayan AP, Kala S, Pani SP. Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India. Tropical Medicine & International Health 2000;5(11):779-785.
179. Reuben R, Rajendran R, Sunish IP, Mani TR, Tewari SC, Hiriyan J, et al. Annual single-dose diethylcarbamazine plus ivermectin for control of bancroftian filariasis: comparative efficacy with and without vector control. Annals of Tropical Medicine and Parasitology 2001;95(4):361-378.
180. Richard-Lenoble D, Chandenier J, Gaxotte P. Ivermectin and filariasis Fundaments and Clinical Pharmacology 2003;17:199-203.
181. Rosbotham JL, Brice GW, Child AH, Nunan TO, Mortimer PS, Burnand KG. Distichiasis-lymphoedema: clinical features, venous function and lymphoscintigraphy. British Journal of Dermatology 2000;142(1):148-152.
182. Rubin A. Filariasis in a tourist diagnosed by fine needle aspiration cytology. Cytopathology 2002;13(6):383-384.
183. Rudra SK, Chandra G. Comparative epidemiological studies on lymphatic filariasis, between tribal and non-tribal populations of Bankura district, West Bengal, India. Annals of Tropical Medicine & Parasitology 2000;94(4):365-372.
184. Sabesan S, Palaniyandi M, Das PK, et al. Mapping of lymphatic filariasis in India. Annals of Tropical Medicine & Parasitology 2000;94(6): 591-606.
185. Sartono E, Lopriore C, Kruize YCM, Kurniawan=Atmadja A, Maizel RM, Yazdanbakhsh M. Reversal in microfilarial density and T cell responses in human lymphatic filariasis.Parasite Immunology 1999;21:565-571.
186. Satapathy AK, Sahoo PK, Geddam JJB, Mohanty MC, Ravindran B. Human Bancroftian filariasis: loss of patent microfilaraemia is not associated with production of antibodies to microfilarial sheath. Parasite Immunology 2001;23(3):163 - 167.
187. Schönemyer A, Lucius R, Sonnenburg B, et al. Modulation of human T cell responses and macrophage functions by Onchocystatin, a secreted protein of the filarial nematode Onchocerca volvulus. The Journal of Immunology 2001; 167:3207-3215.
188. Scott JT, Turner CmR, Mutapi F, Woolhouse MEJ, Ndhlovu PD, Hagan P. Cytokine responses to mitogen and Schistosoma haematobium antigens are different in children with distinct infection histories. Parasite Immunology 2001;23(10):519-526.
189. Seim AR, Dreyer G, Addiss DG. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Revista da Sociedade Brasileira de Medicina Tropical 1999;32(3):325-328.
190. Seketeli A, Adeoye G, Eyamba A, et al. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine & Parasitology 2002;96(Supplement 1):S15-S28.
191. Seminario M-C, Saini SS, MacGlashan DW, Bochner BS. Intracellular expression and release of FceRIa by human eosinophils. The Journal of Immunology 1999;162:6893-6900.
192. Semnani RT, Liu AY, Sabzevari H, et al. Brugia malayi microfilariae induce cell death in human dendritic cells, inhibit their ability to make IL-12 and IL-10, and reduce their capacity to activate CD4+ T cells. The Journal of Immunology 2003;171:1950-1960.
193. Sharma S, Rathaur S. Characterization of secretory acetylcholinesterase from Setaria cervi microfilariae: a potential antigen for diagnosis of human filariasis. Tropical Medicine & International Health 1999;4(5):341-348.
194. Shenoy RK, Sandhya K, Suma TK, VK. A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. Southeast Asian J Trop Med Public Health 1995;26(2):301-305.
195. Shenoy RK, Dalia S, John A, et al. Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses on ivermectin, diethylcarbamazine or albendazole, in various combinations. Annals of Tropical Medicine & Parasitology 1999;93(6):643-651.
196. Shenoy RK, John A, Babu BS, et al. Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations. Annals of Tropical Medicine & Parasitology 2000;94(6):607-614.
197. Shenoy RK, John A, Hameed JS, et al. Apparent failure of ultrasonography to detect adult worms of Brugia malayi. Annals of Tropical Medicine & Parasitology 2000;94(1):77-82.
198. Shriram AN, Murhekar MV, Ramaiah KD, Sehgal SC. Prevalence of diurnally subperiodic bancroftian filariasis among the Nicobarese in Andaman and Nicobar Islands, India: effect of age and gender. Tropical Medicine and International Health 2002;7(11):949-954.
199. Snow LC, Michael E. Transmission dynamics of lymphatic filariasis: density-dependence in the uptake of Wuchereria bancrofti microfilariae by vector mosquitoes. Medical and Veterinary Entomology 2002;16(4):409.
200. Soboslay PT, Geiger SM, Drabner B, Banla M, Batchassi E, Kowu LA, et al. Prenatal immune priming in onchocerciasis Onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers. Clinical & Experimental Immunology 1999;117(1):130-137.
201. Soboslay PT, Lüder CGK, Riesch S, Geiger SM, Banla M, Batchassi E, et al. Regulatory effects of Th1-type (IFN-¡, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls. Immunology 1999;97(2):219-225.
202. Srividya A, Lall R, Ramaiah KD, K.Ramu, Hoti SL, Pani SP, et al. Development of rapid assessment procedures for the delimitation of lymphatic filariasis-endemic areas. Tropical Medicine and International Health 2000;5(1):64-71.
203. Steel C, Ottesen EA, Weller PF, Nutman TB. Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessment from the South Pacific. American Journal of Tropical Medicine and Hygiene 2001;65(5):498-503.
204. Steel C, Ottesen EA, Weller PF, Nutman TB. Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessment from the South Pacific. American Journal of Tropical Medicine and Hygiene 2001;65(5):498-503.
205. Stephenson LS, Holland CV, Cooper ES. The public health significane of Trichuris trichiura Parasitology 2000;121:S73-S95.
206. Stephenson LS, Holland CV, Ottesen EA. Controlling intestinal helminths while eliminating lymphatic filariasis Parasitology 2000;121:S1.
207. Stephenson LS, Latham MC, Ottesen EA. Global Malnutrition Parasitology 2000;121:S5-S22.
208. Stephenson LS, Latham MC, Ottesen EA. Malnutrition and parasitic helminth infections Parasitology 2000;121:S23-S38.
209. Stewart GR, Boussinesq M, Coulson T, Elson L, Nutman T, Bradley JE. Onchocerciasis modulates the immune response to mycobacterial antigens. Clinical & Experimental Immunology 1999;117(3):517-523.
210. Suma TK, Shenoy RK, Kumaraswami V. Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis. Tropical Medicine and International Health 2002;7(9):763-766.
211. Sunish IP, Rajendran R, Mani TR, Gajanana A, Reuben R, Satyanarayana K. Long-term population migration: an important aspect to be considered during mass drug administration for elimination of lymphatic filariasis. Tropical Medicine and International Health 2003;8(4):316-321.
212. Sunish IP, Rajendran R, Mani TR, et al. Transmission intensity index to monitor filariasis infection pressure in vectors for the evaluation of filariasis elimination programme. Tropical Medicine and International Health 2003;8(9):812-819.
213. Sunish IP, Rajendran R, Mani TR, Munirathinam A, Tewari SC, Hiriyan J, et al. Resurgence in filarial transmission after withdrawal of mass drug administration and the relationship between antigenaemia and microfilaraemia - a longitudinal study. Tropical Medicine and International Health 2002;7(1):59-69.
214. Supali T, Ismid IS, Rückert P, Fischer P. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae. Tropical Medicine & International Health 2002;7(10):894-901.
215. Taubert A, Zahner H. Cellular immune responses of filaria (Litomosoides sigmodontis) infected BALB/c mice detected on the level of cytokine transcription. Parasite Immunology 2001;23:253-462.
216. Taylor MJ, Cross HF, Ford L, Makunde WH, Prasad G, Bilo K. Wolbachia bacteria in filarial immunity and disease. Parasite Immunology 2001;23:401-409.
217. Terhell AJ, Haarbrink M, Van Den Biggelaar A, Mangali A, Sartono E, Yazdanbakhsh M. Long-term follow-up of treatment with diethylcarbamazine on anti-filarial IgG4: dosage, compliance, and differential patterns in adults and children. American Journal of Tropical Medicine and Hygiene 2003;68(1):33-39.
218. Terhell AJ, Price R, Koot JWM, Abadi K, Yazdanbakhsh M. The development of specific IgG4 and IgE in a paediatric population is influenced by filarial endemicity and gender. Parasitology 2000;121:535-543.
219. Thomas SY, Hou R, Boyson JE, et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. The Journal of Immunology 2003;171:1571-2580.
220. Thomson MC, Connor SJ. Environmental information systems for the control of arthropod vectors of disease. Medical & Veterinary Entomology 2000;14(3):227-244.
221. Tischendorf FW, Brattig NW, Lintzel M, Büttner DW, Burchard GD, Bork K, et al. Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis. Tropical Medicine & International Health 2000;5(12):898-905.
222. Touré FS, Egwang TG, Millet P, Bain O, Georges AJ, Wahl G. IgG4 serology of loiasis in three villages in an endemic area of south-eastern Gabon. Tropical Medicine & International Health 1998;3(4):313-317.
223. Townson H. Wolbachia as a potential tool for suppressing filarial transmission. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S117-S127.
224. Trouiller P, Battistella C, Pinel J, Pecoul B. Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts. Tropical Medicine & International Health 1999;4(6):412-420.
225. Ungeheuer M-N, Elissa N, Morelli A, Georges AJ, Deloron P, PDebre, et al. Cellular responses to Loa loa experimental infection in mandrills (Mandrillus sphinx) vaccinated with irradiated infective larvae. Parasite Immunology 2000;22(4):173-183.
226. Urbani C, Palmer K. Drug-based helminth control in Western Pacific countries: a general perspective. Tropical Medicine and International Health 2001;6(11):935-944.
227. Uyemura K, Pirmez C, Sieling PA, et al. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires. The Journal of Immunology 1993;151(12):7095-7104.
228. Vaccaro M, Borgia F, Guarneri F, Cannavò SP. Elephantiasis nostras verrucosa. International Journal of Dermatology 2000;39(10):764-773.
229. VanDeWeteringDeRooij J, Driel MFV, Robinson PH, Mensink HJA. Isolated lymphoedema of the external genitalia. Sexual Dysfunction 1998;1(1):53-56.
230. Weil G, Lammie P, Weiss N. The ICT Filariasis Test: A Rapid-format Antigen Test for Diagnosis of Bancroftian Filariasis. Parasitology Today 1997;13(10):401-404.
231. WHO. Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis (in countries where Onchocerciasis is co-endemic). Geneva: WHO 75. Report No.: WHO/CDS/CPE/CEE/2000.16.
232. WHO. Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis (in countries where onchocerciasis is not co-endemic). A Guideline for Programme Managers. Geneva: WHO 2000. Report No.: WHO/CDS/CPE/CEE/2000.15.
233. WHO. Filariasis elimination, Zanzibar. First round of mass drug administration. Weekly epidemiological record 2001;(76(51/52):401-408.
234. WHO. Global elimination of lymphatic filariasis. Progress in the regionalization process, 2001. Weekly epidemiological record 2001;76(50):389-400.
235. WHO. Lymphatic Filariasis. Weekly epidemiological record 2001;76(20):149-156.
236. WHO. Elimination of lymphatic filariasis. Second meeting of the Global Alliance to Eliminate Lymphatic Filariasis, India. Weekly epidemiological record 2002;77(22):177-184.
237. WHO. Lymphatic filariasis. Progress report on mass drug administration in 2001. Weekly epidemiological record 2002;77(16):125-132.
238. WHO. Lymphatic filariasis. Progress report on the Programme in 2002. Weekly epidemiological record 2003;78(20):171-179.
239. WHO. Report of active surveillance for adverse events following the use of drug co-administrations in the Global Programme to Eliminate Lymphatic Filariasis. Weekly epidemiological record 2003;78(36)315-317.
240. WHO. New Hope for People with Lymphedema.
241. Williams SA, Laney SJ, Bierwert LA, Saunders LJ et al. Development and standardization of a rapid, PCR-based method for the detection of Wuchereria bancrofti in mosquitoes, for xenomonitoring the human prevalence of bancroftian filariasis. Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S41-S46.
242. Witt C, Ottesen EA. Lymphatic Filariasis: an infection of childhood. Tropical Medicine and International Health 2001;6(8):582-606.
243. Zagaria N, Savioli L. Elimination of lymphatic filariasis: a public-health challenge Annals of Tropical Medicine & Parasitology 2002;96(Supplement 2):S3-S13.
244. Zaim M, Aitio A, Nakashima N. Review Article: Safety of pyrethroid-treated mosquito nets. Medical & Veterinary Entomology 2000;14(1):1-5.
245. Zang X, Atmadja AK, Gray P, et al. The serpin secreted by Brugia malayimicrofilariae, Bm-SPN-2, elicits strong, but short-lived, immune responses in mice and humans. The Journal of Immunology 2000;165:5161-5169.